Number of times cited according to CrossRef:

Jessica Paige Mead, Andrew Charles Parrott, Mephedrone and MDMA: a comparative review, Brain Research, 10.1016/j.brainres.2020.146740, (146740),

Catharine Montgomery, Carl A. Roberts, Cognitive consequences of 3,4-methylenedioxymethamphetamine use, Cognition and Addiction, 10.1016/B978-0-12-815298-0.00012-5, (165-177),

Phirose Kemprai, Bhaskar Protim Mahanta, Dristi Sut, Rubi Barman, Dipanwita Banik, Mohan Lal, Siddhartha Proteem Saikia, Saikat Haldar, Review on safrole: identity shift of the ‘candy shop’ aroma to a carcinogen and deforester, Flavour and Fragrance Journal, 10.1002/ffj.3521, 35, 1, (5-23),

Katie Anderson, Paula Reavey, Zoë Boden, ‘Never drop without your significant other, cause that way lies ruin’: The boundary work of couples who use MDMA together, International Journal of Drug Policy, 10.1016/j.drugpo.2019.05.004, 71, (10-18),

Maria A Aguilar, Maria P. García-Pardo, Andrew C Parrott, Of mice and men on MDMA: a translational comparison of the neuropsychobiological effects of 3,4-methylenedioxymethamphetamine (‘Ecstasy’), Brain Research, 10.1016/j.brainres.2019.146556, (146556),

Allan J Barnes, Bruno S De Martinis, David A Gorelick, Robert S Goodwin, Erin A Kolbrich, Marilyn A Huestis, Disposition of MDMA and Metabolites in Human Sweat Following Controlled MDMA Administration, Clinical Chemistry, 10.1373/clinchem.2008.117093, 55, 3, (454-462),

Carl A. Roberts, Boris B. Quednow, Catharine Montgomery, Andrew C. Parrott, MDMA and brain activity during neurocognitive performance: An overview of neuroimaging studies with abstinent ‘Ecstasy’ users, Neuroscience & Biobehavioral Reviews, 10.1016/j.neubiorev.2017.07.015, 84, (470-482),

Susan Schenk, David Newcombe, Methylenedioxymethamphetamine (MDMA) in Psychiatry, Journal of Clinical Psychopharmacology, 10.1097/JCP.0000000000000962, 38, 6, (632-638),

Matteo Lazzaretti, Gian Mario Mandolini, Alfredo Carlo Altamura, Paolo Brambilla, Substances of Abuse and Hallucinogenic Activity: The Serotoninergic Pathway - Focus on Classical Hallucinogens and Entactogens, Hallucinations in Psychoses and Affective Disorders, 10.1007/978-3-319-75124-5, (17-31),

Michael Weaver, Hallucinogens, Encyclopedia of Adolescence, 10.1007/978-3-319-33228-4, (1702-1714),

Chao Wei, Xiao Han, Danwei Weng, Qiru Feng, Xiangbing Qi, Jin Li, Minmin Luo, Response dynamics of midbrain dopamine neurons and serotonin neurons to heroin, nicotine, cocaine, and MDMA, Cell Discovery, 10.1038/s41421-018-0060-z, 4, 1,

Bonnaire Céline, Beck François, Spilka Stanislas, Physical and psychosocial factors associated with psychostimulants use in a nationally representative sample of French adolescents: Specificities of cocaine, amphetamine, and ecstasy use, Addictive Behaviors, 10.1016/j.addbeh.2018.11.046,

Khary K. Rigg, Amanda Sharp, Deaths related to MDMA (ecstasy/molly): Prevalence, root causes, and harm reduction interventions, Journal of Substance Use, 10.1080/14659891.2018.1436607, 23, 4, (345-352),

Maartje M. L. de Win, Gerry Jager, Jan Booij, Liesbeth Reneman, Thelma Schilt, Cristina Lavini, Sílvia D. Olabarriaga, Nick F. Ramsey, Gerard J. den Heeten, Wim van den Brink, Neurotoxic effects of ecstasy on the thalamus, British Journal of Psychiatry, 10.1192/bjp.bp.106.035089, 193, 4, (289-296),

Jeremy I. Webster, David N. Harper, Susan Schenk, Generalization of serotonin and dopamine ligands to the discriminative stimulus effects of different doses of ±3,4-methylenedioxymethamphetamine, Behavioural Pharmacology, 10.1097/FBP.0000000000000282, 28, 4, (245-254),

Giulia Costa, Micaela Morelli, Nicola Simola, Progression and Persistence of Neurotoxicity Induced by MDMA in Dopaminergic Regions of the Mouse Brain and Association with Noradrenergic, GABAergic, and Serotonergic Damage, Neurotoxicity Research, 10.1007/s12640-017-9761-6, 32, 4, (563-574),

Andrew C Parrott, Luke A Downey, Carl A Roberts, Cathy Montgomery, Raimondo Bruno, Helen C Fox, Recreational 3,4-methylenedioxymethamphetamine or ‘ecstasy’: Current perspective and future research prospects, Journal of Psychopharmacology, 10.1177/0269881117711922, 31, 8, (959-966),

Marit Edland-Gryt, Sveinung Sandberg, Willy Pedersen, From ecstasy to MDMA: Recreational drug use, symbolic boundaries, and drug trends, International Journal of Drug Policy, 10.1016/j.drugpo.2017.07.030, 50, (1-8),

Rozemarijn Witkam, Karin Monshouwer, Yvonne Drost, Margriet van Laar, Peggy van der Pol, Wat doen XTC-gebruikers om risico’s te beperken?Which harm reduction strategies do ecstasy users perform?, Verslaving, 10.1007/s12501-017-0111-4, 13, 2, (102-119),

Michael D. Wunderli, Matthias Vonmoos, Marina Fürst, Katrin Schädelin, Thomas Kraemer, Markus R. Baumgartner, Erich Seifritz, Boris B. Quednow, Discrete memory impairments in largely pure chronic users of MDMA, European Neuropsychopharmacology, 10.1016/j.euroneuro.2017.08.425, 27, 10, (987-999),

Anya K. Bershad, Melissa A. Miller, Harriet de Wit, MDMA does not alter responses to the Trier Social Stress Test in humans, Psychopharmacology, 10.1007/s00213-017-4621-x, 234, 14, (2159-2166),

Nga Thi Thu Vu, Martin Holt, Huong Thi Thu Phan, Lan Thi La, Gioi Minh Tran, Tung Thanh Doan, Trang Nguyen Nhu Nguyen, John de Wit, Amphetamine-Type-Stimulants (ATS) Use and Homosexuality-Related Enacted Stigma Are Associated With Depression Among Men Who Have Sex With Men (MSM) in Two Major Cities in Vietnam in 2014, Substance Use & Misuse, 10.1080/10826084.2017.1284233, 52, 11, (1411-1419),

Concepción Roger-Sánchez, María P. García-Pardo, Marta Rodríguez-Arias, Jose Miñarro, María A. Aguilar, Neurochemical substrates of the rewarding effects of MDMA, Behavioural Pharmacology, 10.1097/FBP.0000000000000210, 27, (116-132),

Michael Weaver, Hallucinogens, Encyclopedia of Adolescence, 10.1007/978-3-319-32132-5, (1-13),

Andrew C. Parrott, Oxytocin, cortisol and 3,4-methylenedioxymethamphetamine, Behavioural Pharmacology, 10.1097/FBP.0000000000000262, 27, 8, (649-658),

Thomas S. Ray, Constructing the ecstasy of MDMA from its component mental organs: Proposing the primer/probe method, Medical Hypotheses, 10.1016/j.mehy.2015.12.018, 87, (48-60),

Lucia Frau, Nicola Simola, Pier Francesca Porceddu, Micaela Morelli, Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brain, NeuroToxicology, 10.1016/j.neuro.2016.07.008, 56, (127-138),

Gary Groth-Marnat, Hennedy Howchar, Ali Marsh, Memory Performance in Abstinent 3,4-Methylenedioxymethamphetamine (Mdma, “Ecstasy”) Users, Perceptual and Motor Skills, 10.2466/pms.104.1.43-55, 104, 1, (43-55),

David M. Compton, Melissa C. Selinger, Erin K. Testa, Krystal D. Larkins, An Examination of the Effects of 5-Methoxy-N,N-di(iso)propyltryptamine Hydrochloride (Foxy) on Cognitive Development in Rats, Psychological Reports, 10.2466/pr0.98.3.651-661, 98, 3, (651-661),

Joanna K. Huxster, Alessandro Pirona, Michael J. Morgan, The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans, Journal of Psychopharmacology, 10.1177/0269881106060513, 20, 2, (281-290),

Neil Easton, Charles A. Marsden, Ecstasy: Are animal data consistent between species and can they translate to humans?, Journal of Psychopharmacology, 10.1177/0269881106061153, 20, 2, (194-210),

Andy C. Parrott, MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress, Journal of Psychopharmacology, 10.1177/0269881106063268, 20, 2, (147-163),

Maartje M. L. de Win, Thelma Schilt, Liesbeth Reneman, Hylke Vervaeke, Gerry Jager, Sarah Dijkink, Jan Booij, Wim van den Brink, Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study, Journal of Psychopharmacology, 10.1177/0269881106063275, 20, 2, (226-235),

G. J. H. Dumont, R. J. Verkes, A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers, Journal of Psychopharmacology, 10.1177/0269881106063271, 20, 2, (176-187),

A. C. Parrott, Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy, Journal of Psychopharmacology, 10.1177/0269881105048900, 19, 1, (71-83),

Kim P. C. Kuypers, Jan G. Ramaekers, Transient memory impairment after acute dose of 75mg 3.4-Methylene-dioxymethamphetamine, Journal of Psychopharmacology, 10.1177/0269881105056670, 19, 6, (633-639),

Harry R. Sumnall, Jon C. Cole, Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysis, Journal of Psychopharmacology, 10.1177/0269881105048901, 19, 1, (84-92),

A. C. Parrott, E. Gouzoulis-Meyfrank, J. Rodgers, N. Solowij, Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects, Journal of Psychopharmacology, 10.1177/0269881104047286, 18, 4, (572-576),

A. C. Parrott, E. Gouzoulis-Meyfrank, J. Rodgers, N. Solowij, Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects, Journal of Psychopharmacology, 10.1177/026988110401800416, 18, 4, (572-575),

Ben J. Harrison, James S. Olver, Trevor R. Norman, Graham D. Burrows, Keith A. Wesnes, Pradeep J. Nathan, Selective Effects of Acute Serotonin and Catecholamine Depletion on Memory in Healthy Women, Journal of Psychopharmacology, 10.1177/0269881104040225, 18, 1, (32-40),

K. Soar, A. C. Parrott, H. C. Fox, Persistent Neuropsychological Problems after 7 Years of Abstinence from Recreational Ecstasy (MDMA): A Case Study, Psychological Reports, 10.2466/pr0.95.1.192-196, 95, 1, (192-196),

H. C. Fox, A. C. Parrott, Selective Neurocognitive Deficits Associated with Multiple Doses of Ecstasy/MDMA: A Reply to Cole, Journal of Psychopharmacology, 10.1177/0269881103017002016, 17, 2, (242-244),

Andrine M. Lemieux, Bingshuo Li, Mustafa al’Absi, Khat use and appetite: An overview and comparison of amphetamine, khat and cathinone, Journal of Ethnopharmacology, 10.1016/j.jep.2014.11.002, 160, (78-85),

Steven Karch, Olaf Drummer, Hallucinogens, Karch's Pathology of Drug Abuse, Fifth Edition, 10.1201/b18962, (365-428),

Fabio Del Bello, Farhana Sakloth, John S. Partilla, Michael H. Baumann, Richard A. Glennon, Ethylenedioxy homologs of N -methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine, Bioorganic & Medicinal Chemistry, 10.1016/j.bmc.2015.07.035, 23, 17, (5574-5579),

Helen J. Cassaday, What’s Special about the Ethical Challenges of Studying Disorders with Altered Brain Activity?, Ethical Issues in Behavioral Neuroscience, 10.1007/7854_2014_333, (137-157),

Aimee L. May, Andrew C. Parrott, Greater sexual risk‐taking in female and male recreational MDMA/ecstasy users compared with alcohol drinkers: a questionnaire study, Human Psychopharmacology: Clinical and Experimental, 10.1002/hup.2432, 30, 4, (272-275),

Andrew C. Parrott, Why all stimulant drugs are damaging to recreational users: an empirical overview and psychobiological explanation, Human Psychopharmacology: Clinical and Experimental, 10.1002/hup.2468, 30, 4, (213-224),

Nga Thi Thu Vu, Lisa Maher, Iryna Zablotska, Amphetamine‐type stimulants and HIV infection among men who have sex with men: implications on HIV research and prevention from a systematic review and meta‐analysis, Journal of the International AIDS Society, 10.7448/IAS.18.1.19273, 18, 1,

Arthur MacNeill Horton, Henry V. Soper, Teri J. McHale, Understanding the Neuropsychology of Substance Abuse in Men, The Neuropsychology of Men, 10.1007/978-1-4899-7615-4_6, (133-147),

Natasha E. Wright, Judith A. Strong, Erika R. Gilbart, Skyler G. Shollenbarger, Krista M. Lisdahl, 5-HTTLPR Genotype Moderates the Effects of Past Ecstasy Use on Verbal Memory Performance in Adolescent and Emerging Adults: A Pilot Study, PLOS ONE, 10.1371/journal.pone.0134708, 10, 7, (e0134708),

Carla Ruis, Albert Postma, Willem Bouvy, Ineke van der Ham, Cognitive disorders after sporadic ecstasy use? A case report, Neurocase, 10.1080/13554794.2014.894530, 21, 3, (351-357),

Andrew C. Parrott, MDMA is certainly damaging after 25 years of empirical research: a reply and refutation of Doblin et al. (2014), Human Psychopharmacology: Clinical and Experimental, 10.1002/hup.2390, 29, 2, (109-119),

Torbjørn Breivik, Inger Lise Bogen, Kristin Huse Haug, Frode Fonnum, Per-Kristian Opstad, Dag Marcus Eide, Oddvar Myhre, Effects of long-term exposure of 3,4-methylenedioxymethamphetamine (MDMA; “ecstasy”) on neuronal transmitter transport, brain immuno-regulatory systems and progression of experimental periodontitis in rats, Neurochemistry International, 10.1016/j.neuint.2014.04.002, 72, (30-36),

Claire White, Mark Edwards, John Brown, Jason Bell, The impact of recreational MDMA ‘ecstasy’ use on global form processing, Journal of Psychopharmacology, 10.1177/0269881114546709, 28, 11, (1018-1029),

Andrew C Parrott, Lucy Young, Saturday night fever in ecstasy/MDMA dance clubbers: Heightened body temperature and associated psychobiological changes, Temperature, 10.4161/23328940.2014.977182, 1, 3, (214-219),

Andreas Büttner, The Neuropathology of Drug Abuse, The Effects of Drug Abuse on the Human Nervous System, 10.1016/B978-0-12-418679-8.00007-1, (169-202),

Claire White, John Brown, Mark Edwards, Alterations to global but not local motion processing in long-term ecstasy (MDMA) users, Psychopharmacology, 10.1007/s00213-014-3431-7, 231, 13, (2611-2622),

Andrew C. Parrott, The Potential Dangers of Using MDMA for Psychotherapy, Journal of Psychoactive Drugs, 10.1080/02791072.2014.873690, 46, 1, (37-43),

Asuka Kaizaki, Sachiko Tanaka, Takemi Yoshida, Satoshi Numazawa, Maternal MDMA administration in mice leads to neonatal growth delay, The Journal of Toxicological Sciences, 10.2131/jts.39.33, 39, 1, (33-39),

Andrew C. Parrott, Derek G. Moore, John J.D. Turner, Julia Goodwin, Meeyoung O. Min, Lynn T. Singer, MDMA and heightened cortisol: a neurohormonal perspective on the pregnancy outcomes of mothers used ‘Ecstasy’ during pregnancy, Human Psychopharmacology: Clinical and Experimental, 10.1002/hup.2342, 29, 1, (1-7),

Jenessa S. Price, Paula Shear, Krista M. Lisdahl, Ecstasy Exposure & Gender: Examining Components of Verbal Memory Functioning, PLoS ONE, 10.1371/journal.pone.0115645, 9, 12, (e115645),

Diana Dias Silva, Elisabete Silva, Félix Carvalho, Helena Carmo, Mixtures of 3,4‐methylenedioxymethamphetamine (ecstasy) and its major human metabolites act additively to induce significant toxicity to liver cells when combined at low, non‐cytotoxic concentrations, Journal of Applied Toxicology, 10.1002/jat.2885, 34, 6, (618-627),

Lynn Taurah, Chris Chandler, Geoff Sanders, Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy), Psychopharmacology, 10.1007/s00213-013-3288-1, 231, 4, (737-751),

Robert J. Tait, Amanda George, Sarah Olesen, ‘Ecstasy’ and the use of sleep medications in a general community sample: a 4‐year follow‐up, Addiction, 10.1111/add.12200, 108, 9, (1640-1648),

Andrew C. Parrott, Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research, Human Psychopharmacology: Clinical and Experimental, 10.1002/hup.2318, 28, 4, (289-307),

Rowan P. Ogeil, Shantha M.W. Rajaratnam, Jillian H. Broadbear, Male and female ecstasy users: Differences in patterns of use, sleep quality and mental health outcomes, Drug and Alcohol Dependence, 10.1016/j.drugalcdep.2013.02.002, 132, 1-2, (223-230),

Andrew C. Parrott, MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational ‘Ecstasy’ users, Neuroscience & Biobehavioral Reviews, 10.1016/j.neubiorev.2013.04.016, 37, 8, (1466-1484),

D.N. Harper, C. Kay, M. Hunt, Prior MDMA exposure inhibits learning and produces both tolerance and sensitization in the radial-arm maze, Pharmacology Biochemistry and Behavior, 10.1016/j.pbb.2013.01.018, 105, (34-40),

Matthew G. Kirkpatrick, Margaret C. Wardle, Experimental Methods for Understanding the Role of Social Context in Drug Addiction, The Wiley‐Blackwell Handbook of Addiction Psychopharmacology, 10.1002/9781118384404, (515-540),

Clara Ros‐Simó, Maria Moscoso‐Castro, Jéssica Ruiz‐Medina, Joaquim Ros, Olga Valverde, Memory impairment and hippocampus specific protein oxidation induced by ethanol intake and 3, 4‐Methylenedioxymethamphetamine (MDMA) in mice, Journal of Neurochemistry, 10.1111/jnc.12247, 125, 5, (736-746),

Loralie Langman, Laura Bechtel, Christopher P. Holstege, Clinical Toxicology, Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 10.1016/B978-1-4160-6164-9.00035-4, (1109-1188),

Samanta Yubero-Lahoz, Mario A. Ayestas, Bruce E. Blough, John S. Partilla, Richard B. Rothman, Rafael de la Torre, Michael H. Baumann, Effects of MDMA and related analogs on plasma 5-HT: Relevance to 5-HT transporters in blood and brain, European Journal of Pharmacology, 10.1016/j.ejphar.2011.10.033, 674, 2-3, (337-344),

Hugo Lövheim, A new three-dimensional model for emotions and monoamine neurotransmitters, Medical Hypotheses, 10.1016/j.mehy.2011.11.016, 78, 2, (341-348),

A.C. Parrott, MDMA and temperature: A review of the thermal effects of ‘Ecstasy’ in humans, Drug and Alcohol Dependence, 10.1016/j.drugalcdep.2011.08.012, 121, 1-2, (1-9),

Márcia Carvalho, Helena Carmo, Vera Marisa Costa, João Paulo Capela, Helena Pontes, Fernando Remião, Félix Carvalho, Maria de Lourdes Bastos, Toxicity of amphetamines: an update, Archives of Toxicology, 10.1007/s00204-012-0815-5, 86, 8, (1167-1231),

A. C. Parrott, MDMA and LSD, Drug Abuse and Addiction in Medical Illness, 10.1007/978-1-4614-3375-0, (175-188),

AC Parrott, P Murphy, AB Scholey, Applied human psychopharmacology: the practical psychobiological consequences of some novel and ancient psychoactive drugs, Human Psychopharmacology: Clinical and Experimental, 10.1002/hup.2221, 27, 2, (103-105),

David N. Harper, Attenuation of the disruptive effects of (+/‐)3,4‐methylenedioxymethamphetamine and cocaine on delayed matching‐to‐sample performance with D1 versus D2 antagonists, Addiction Biology, 10.1111/j.1369-1600.2011.00389.x, 18, 6, (912-920),

Jennifer Do, Susan Schenk, Self‐administered MDMA produces dose‐ and time‐dependent serotonin deficits in the rat brain, Addiction Biology, 10.1111/j.1369-1600.2011.00370.x, 18, 3, (441-447),

N. Fernàndez‐Castillo, M. J. Orejarena, M. Ribasés, E. Blanco, M. Casas, P. Robledo, R. Maldonado, B. Cormand, Active and passive MDMA (‘ecstasy’) intake induces differential transcriptional changes in the mouse brain, "Genes, Brain and Behavior", 10.1111/j.1601-183X.2011.00735.x, 11, 1, (38-51),

A. Büttner, Review: The neuropathology of drug abuse, Neuropathology and Applied Neurobiology, 10.1111/j.1365-2990.2010.01131.x, 37, 2, (118-134),

J H P van Wel, K P C Kuypers, E L Theunissen, W M Bosker, K Bakker, J G Ramaekers, Blockade of 5-HT2 Receptor Selectively Prevents MDMA-Induced Verbal Memory Impairment, Neuropsychopharmacology, 10.1038/npp.2011.80, 36, 9, (1932-1939),

Rie Ikeda, Yoshiko Igari, Yuki Fuchigami, Mitsuhiro Wada, Naotaka Kuroda, Kenichiro Nakashima, Pharmacodynamic interactions between MDMA and concomitants in MDMA tablets on extracellular dopamine and serotonin in the rat brain, European Journal of Pharmacology, 10.1016/j.ejphar.2011.03.050, 660, 2-3, (318-325),

Maarten van den Buuse, Thorsten Becker, Perrin Kwek, Sally Martin, Emma Ruimschotel, Victoria Risbrough, Disruption of prepulse inhibition by 3,4-methylenedioxymethamphetamine (MDMA): comparison between male and female wild-type and 5-HT1A receptor knockout mice, The International Journal of Neuropsychopharmacology, 10.1017/S1461145711000101, 14, 06, (856-861),

Wael M.Y. Mohamed, Sami Ben Hamida, Jean-Christophe Cassel, Anne Pereira de Vasconcelos, Byron C. Jones, MDMA: Interactions with other psychoactive drugs, Pharmacology Biochemistry and Behavior, 10.1016/j.pbb.2011.06.032, 99, 4, (759-774),

Deirdre A. Conroy, Kirk J. Brower, Alcohol, toxins, and medications as a cause of sleep dysfunction, Sleep Disorders, 10.1016/B978-0-444-52006-7.00038-1, (587-612),

Samanta Yubero-Lahoz, Ricardo Pardo, Magí Farré, Brian OʼMahony, Marta Torrens, Cristina Mustata, Clara Pérez-Mañá, Marcellí Carbó, Rafael de la Torre, Sex Differences in 3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy)-Induced Cytochrome P450 2D6 Inhibition in Humans, Clinical Pharmacokinetics, 10.2165/11584550-000000000-00000, 50, 5, (319-329),

Irene Antolino-Lobo, Jan Meulenbelt, Martin van den Berg, Majorie B.M. van Duursen, A mechanistic insight into 3,4-methylenedioxymethamphetamine (“ecstasy”)-mediated hepatotoxicity, Veterinary Quarterly, 10.1080/01652176.2011.642534, 31, 4, (193-205),

Lwendo S. Moonzwe, Jean J. Schensul, Kristin M. Kostick, The Role of MDMA (Ecstasy) in Coping with Negative Life Situations Among Urban Young Adults, Journal of Psychoactive Drugs, 10.1080/02791072.2011.605671, 43, 3, (199-210),

Erica Y. Shen, Syed F. Ali, Jerrold S. Meyer, Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats, Neuropharmacology, 10.1016/j.neuropharm.2011.07.002, 61, 8, (1183-1192),

María Juliana Orejarena, Laurence Lanfumey, Rafael Maldonado, Patricia Robledo, Involvement of 5-HT2A receptors in MDMA reinforcement and cue-induced reinstatement of MDMA-seeking behaviour, International Journal of Neuropsychopharmacology, 10.1017/S1461145710001215, 14, 7, (927-940),

C. Kay, D.N. Harper, M. Hunt, The effects of binge MDMA on acquisition and reversal learning in a radial-arm maze task, Neurobiology of Learning and Memory, 10.1016/j.nlm.2011.02.010, 95, 4, (473-483),

Susan Schenk, MDMA (“ecstasy”) abuse as an example of dopamine neuroplasticity, Neuroscience & Biobehavioral Reviews, 10.1016/j.neubiorev.2010.12.010, 35, 5, (1203-1218),

Andrew C. Parrott, Amy Gibbs, Andrew B. Scholey, Rebecca King, Katherine Owens, Phil Swann, Ed Ogden, Con Stough, MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study, Psychopharmacology, 10.1007/s00213-011-2184-9, 215, 3, (527-536),

Claire Nulsen, Allison Fox, Geoff Hammond, Electrophysiological indices of altered working memory processes in long‐term ecstasy users, Human Psychopharmacology: Clinical and Experimental, 10.1002/hup.1231, 26, 7, (488-497),

Elena Puerta, Norberto Aguirre, Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): Neurodegeneration versus Neuromodulation, Pharmaceuticals, 10.3390/ph4070992, 4, 7, (992-1018),

H. M. Francis, N. J. Kraushaar, L. R. Hunt, J. L. Cornish, Serotonin 5-HT4 receptors in the nucleus accumbens are specifically involved in the appetite suppressant and not locomotor stimulant effects of MDMA (‘ecstasy’), Psychopharmacology, 10.1007/s00213-010-1982-9, 213, 2-3, (355-363),

GJH Dumont, JGC van Hasselt, M de Kam, JMA van Gerven, DJ Touw, JK Buitelaar, RJ Verkes, Acute psychomotor, memory and subjective effects of MDMA and THC co-administration over time in healthy volunteers, Journal of Psychopharmacology, 10.1177/0269881110376687, 25, 4, (478-489),